38.85 -0.46 (-1.17%)
After hours: 6:38PM EDT
|Bid||39.20 x 800|
|Ask||41.02 x 800|
|Day's range||38.66 - 42.96|
|52-week range||25.08 - 79.46|
|Beta (5Y monthly)||1.29|
|PE ratio (TTM)||16.62|
|Forward dividend & yield||2.08 (5.50%)|
|Ex-dividend date||12 Mar 2020|
|1y target est||70.50|
Union Square Hospitality Group founder and CEO Danny Meyer discusses the state of the restaurant industry amidst the height of the coronavirus outbreak.
Unfortunately for some shareholders, the Restaurant Brands International (NYSE:QSR) share price has dived 31% in the...
Yahoo Finance speaks with Chipotle CEO Brian Niccol on the state of his restaurant business amidst the coronavirus.
Investors need to pay close attention to Restaurant Brands (QSR) stock based on the movements in the options market lately.
Grubhub founder and CEO Matt Maloney talks with Yahoo Finance about how the food delivery business is navigating the coronavirus pandemic.
Yahoo Finance catches up with Yum! Brands CEO David Gibbs to discuss how his business is faring during the coronavirus.
(Bloomberg) -- Bill Ackman said he has invested a portion of his personal wealth to help manufacture antibody testing kits produced by Covaxx, a newly formed subsidiary of closely-held United Biomedical Inc., amid the outbreak of the coronavirus.Ackman has repeatedly called for a complete shutdown of the U.S. for 30-days to help combat the spread of the Covid-19 virus. He has also called for antibody testing, like the one Covaxx develops, across the country to determine who has been contracted the virus.“The key to a successful reopening beyond the maintenance of social distancing, hand washing, mask use and other related practices is a broad-based testing regime and tracing program,” Ackman said in a letter on Wednesday to investors in his hedge fund, Pershing Square Capital Management.“This will enable the inevitable viral breakouts to be identified early and minimized with localized quarantines, reducing the impact on the overall U.S. economy and the need for future shutdowns,” he said.HedgesAckman made a roughly 100 times return on hedges he had put in place to protect Pershing Squares’ $6.6 billion portfolio against the impact of the virus, according to the letter.His firm paid roughly $27 million for the hedges, which were made in the form of purchases of credit protection on investment-grade and high-yield credit indices. The hedges generated $2.6 billion in proceeds by the time he exited them on March 23.He said he has since redeployed the capital by investing further in his portfolio companies, including Lowe’s Cos., Agilent Technologies Inc., Hilton Worldwide Holdings Inc., Restaurant Brands International Inc., and Warren Buffett’s Berkshire Hathaway Inc. He also reinvested in Starbucks Corp.“The proceeds of the hedges have enabled us to become a substantially larger shareholder of a number of our portfolio companies, and to add some new investments, all at deeply discounted prices,” he said.Ackman said in an interview on CNBC on March 18 that “hell is coming” if drastic measures were not taken to combat the virus. A week later, he said in an interview with Bloomberg TV he had made a $2.5 billion “recovery bet” on a bounceback, after gaining confidence “that the president and his team are heading in the right direction.”Covaxx has already deployed over 100,000 Covid-19 tests in China, and is currently testing in San Miguel County, Colorado. The company believes it can scale the tests to hundreds of millions in “relative short order,” Ackman said. The billionaire made the investment through the Pershing Square Foundation, which manages his personal wealth. He did not disclose the size of the investment.Health officials in San Miguel County, home of the popular ski-town Telluride, teamed up with United Biomedical earlier this month to collect blood samples to test the kits and provide free screening to people in the area.The tests can determine whether a person has been infected by Covid-19 within hours, rather than the days it takes for the current, drive-thru nasal swab tests.Broader antibody based screen will give an accurate estimate of what percentage of the population is infected, Ackman said. That will allow more accurate data on the virus’s characteristics, such as how many people become critically ill and how many have only limited symptoms.“Imagine how differently and effectively we could have managed this crisis if we actually knew who was infected,” he said.United Biomedical has spent years producing vaccines for animals and working on human treatments for diseases like Alzheimer’s and Parkinson’s. It manufacturers its test kits on Long Island, New York.The company has been around for more than three decades. Its animal vaccines have been used to protect billions of farm animals from foot-and-mouth disease and to chemically castrate pigs. It also has developed blood-screening kits and a test for SARS, or Severe Acute Respiratory Syndrome.“We believe it is inevitable that in order to halt the advance of the virus and preserve the ability of local, city, and state health-care systems to deal with the volume of critical care patients, nearly all states will eventually initiate strong-form, non-essential business closures and stay-at-home regulations,” Ackman said.(Updates with additional details in the final paragraph; An earlier version of this report corrected the return on Ackman’s hedges)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Restaurant Brands CEO Jose Cil shares what he discussed with President Trump and several other restaurant industry leaders.
Unfortunately for some shareholders, the Restaurant Brands International (NYSE:QSR) share price has dived 35% in the...
Restaurant Brands (QSR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Restaurant Brands International Inc. (NYSE:QSR) is about to trade ex-dividend in the next 4 days. If you purchase the...
Wendy's has re-entered the breakfast wars. Yahoo Finance goes behind the scenes of the big launch with Wendy's CEO Todd Penegor.
Yahoo Finance talks with Beyond Meat founder and CEO Ethan Brown fresh off its latest earnings report.
Papa John's reported a beat on the top and bottom lines during its fourth quarter and same-store sales in the U.S. that exceeded Wall Street estimates.
The Burger King® brand has pulled a surprising, global, integrated advertising campaign showing its iconic Whopper® sandwich covered in mold. Yes, you read it right. A Whopper® sandwich covered in mold. Instead of featuring its product with the classic, flawless, and often perfect photographic style commonly used to showcase fast food products, the Burger King® brand let its most iconic product rot to make a powerful statement: The brand has achieved a milestone by removing artificial preservatives from the Whopper® sandwich, in most European countries and select markets in the United States*.